Laying to rest psychostimulants for cancer-related fatigue?

Journal of Clinical Oncology

Volumn 32, Issue 18, 2014, Pages 1865-1867

  Ruddy, Kathryn J ^a   Barton, Debra ^b   Loprinzi, Charles L ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARMODAFINIL; DEXAMETHASONE; METHYLPHENIDATE; MODAFINIL; PSYCHOSTIMULANT AGENT; BENZHYDRYL DERIVATIVE; CENTRAL STIMULANT AGENT;

CANCER FATIGUE; CANCER PATIENT; CANCER THERAPY; EDITORIAL; HUMAN; PANAX QUINQUEFOLIUS; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); FATIGUE; FEMALE; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; NOTE;

BENZHYDRYL COMPOUNDS; CARCINOMA, NON-SMALL-CELL LUNG; CENTRAL NERVOUS SYSTEM STIMULANTS; FATIGUE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; METHYLPHENIDATE;

EID: 84905396519     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.55.8353     Document Type: Editorial

References (57)

1. Wang XS, Zhao F, Fisch MJ, et al: Prevalence and characteristics of moderate to severe fatigue: A multicenter study in cancer patients and survivors. Cancer 120:425-432, 2014
2. Langston B, Armes J, Levy A, et al: The prevalence and severity of fatigue in men with prostate cancer: A systematic review of the literature. Support Care Cancer 21:1761-1771, 2013
3. Karthikeyan G, Jumnani D, Prabhu R, et al: Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of life: A cross-sectional study. Indian J Palliat Care 18:165-175, 2012
4. Mota DD, Pimenta CA, Caponero R: Fatigue in colorectal cancer patients: Prevalence and associated factors. Revista Latino-Americana de Enfermagem 20:495-503, 2012
5. Mustian KM, Morrow GR, Carroll JK, et al: Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist 12:52-67, 2007 (suppl 1)
6. Spichiger E, Müller-Fröhlich C, Denhaerynck K, et al: Prevalence and contributors to fatigue in individuals hospitalized with advanced cancer: A prospective, observational study. Int J Nurs Stud 49:1146-1154, 2012
7. Garabeli Cavalli Kluthcovsky AC, Urbanetz AA, de Carvalho DS, et al: Fatigue after treatment in breast cancer survivors: Prevalence, determinants and impact on health-related quality of life. Support Care Cancer 20:1901-1909, 2012
8. Singer S, Kuhnt S, Zwerenz R, et al: Age- and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients. Br J Cancer 105:445-451, 2011
9. Kuhnt S, Ernst J, Singer S, et al: Fatigue in cancer survivors: Prevalence and correlates. Onkologie 32:312-317, 2009
10. Bruera E, Chadwick S, Brenneis C, et al: Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep 71:67-70, 1987 (Pubitemid 17003435)
11. DeLong R, Friedman H, Friedman N, et al: Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia. J Child Neurol 7:462-463, 1992
12. Weitzner MA, Meyers CA, Valentine AD: Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment. J Neuropsychiatry Clin Neurosci 7:347-350, 1995
13. Olin J, Masand P: Psychostimulants for depression in hospitalized cancer patients. Psychosomatics 37:57-62, 1996 (Pubitemid 26021821)
14. Masand P, Chaudhary P: Methylphenidate treatment of poststroke depression in a patient with global aphasia. Ann Clin Psychiatry 6:271-274, 1994
15. Lazarus LW, Moberg PJ, Langsley PR, et al: Methylphenidate and nortriptyline in the treatment of poststroke depression: A retrospective comparison. Arch Phys Med Rehabil 75:403-406, 1994 (Pubitemid 24134116)
16. Bruera E, Fainsinger R, MacEachern T, et al: The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report. Pain 50:75-77, 1992
17. Homsi J, Walsh D, Nelson KA: Psychostimulants in supportive care. Support Care Cancer 8:385-397, 2000 (Pubitemid 30650523)
18. Homsi J, Nelson KA, Sarhill N, et al: A phase II study of methylphenidate for depression in advanced cancer. Am J Hosp Palliat Care 18:403-407, 2001
19. Meyers CA, Weitzner MA, Valentine AD, et al: Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 16:2522-2527, 1998 (Pubitemid 28309050)
20. Sarhill N, Walsh D, Nelson KA, et al: Methylphenidate for fatigue in advanced cancer: A prospective open-label pilot study. Am J Hosp Palliat Care 18:187-192, 2001
21. Sugawara Y, Akechi T, Shima Y, et al: Efficacy of methylphenidate for fatigue in advanced cancer patients: A preliminary study. Palliat Med 16:261-263, 2002 (Pubitemid 34537672)
22. Bruera E, Driver L, Barnes EA, et al: Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: A preliminary report. J Clin Oncol 21:4439-4443, 2003 (Pubitemid 46621822)
23. Johnson RL, Block I, Gold MA, et al: Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer. Psycho-oncology 19:955-958, 2010
24. Roth AJ, Nelson C, Rosenfeld B, et al: Methylphenidate for fatigue in ambulatory men with prostate cancer. Cancer 116:5102-5110, 2010
25. Lower EE, Fleishman S, Cooper A, et al: Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: A randomized clinical trial. J Pain Symptom Manage 38:650-662, 2009
26. Bruera E, Valero V, Driver L, et al: Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 24:2073-2078, 2006 (Pubitemid 46622117)
27. Bruera E, Yennurajalingam S, Palmer JL, et al: Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: A randomized, placebo-controlled, phase II trial. J Clin Oncol 31:2421-2427, 2013
28. Moraska AR, Sood A, Dakhil SR, et al: Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol 28:3673-3679, 2010
29. Escalante CP, Meyers C, Reuben JM, et al: A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J 20:8-14, 2014
30. Spathis A, Dhillan R, Booden D, et al: Modafinil for the treatment of fatigue in lung cancer: A pilot study. Palliat Med 23:325-331, 2009
31. Blackhall L, Petroni G, Shu J, et al: A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue. J Palliat Med 12:433-439, 2009
32. Spathis A, Fife K, Blackhall F, et al: Modafinil for the treatment of fatigue in lung cancer: Results of a placebo-controlled, double-blind, randomized trial. J Clin Oncol 32:1882-1888, 2014
33. Jean-Pierre P, Morrow GR, Roscoe JA, et al: A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: A University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer 116:3513-3520, 2010
34. Shaw EG, Case D, Bryant D, et al: Phase II double-blind placebo-controlled study of armodafinil for brain radiation induced fatigue. J Clin Oncol 31:576s, 2013 (suppl 15; abstr 9505)
35. NCCN Guidelines for Cancer-Related Fatigue, NCCN Clinical Practice Guidelines in Oncology: Supportive Care 2014. www.nccn.org/professionals/ physician-gls/PDF/fatigue.pdf
36. National Cancer Institute: Cancer topics: Fatigue intervention; health professional version. www.cancer.gov/cancertopics/pdq/supportivecare/fatigue/ healthprofessional/page1/allpages
37. Rozans M, Dreisbach A, Lertora JJ, et al: Palliative uses of methylphenidate in patients with cancer: A review. J Clin Oncol 20:335-339, 2002 (Pubitemid 34032629)
38. Wilwerding MB, Loprinzi CL, Mailliard JA, et al: A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics. Support Care Cancer 3:135-138, 1995
39. Yennurajalingam S, Frisbee-Hume S, Palmer JL, et al: Reduction of cancer-related fatigue with dexamethasone: A double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol 31:3076-3082, 2013
40. Barton DL, Soori GS, Bauer BA, et al: Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: A randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer 18:179-187, 2010
41. Barton DL, Liu H, Dakhil SR, et al: Wisconsin ginseng (Panax quinquefolius) to improve cancer-related fatigue: A randomized, double-blind trial, N07C2. J Natl Cancer Inst 105:1230-1238, 2013
42. Wang J, Sun C, Zheng Y, et al: The effective mechanism of the polysaccharides from Panax ginseng on chronic fatigue syndrome. Arch Pharm Res 37:530-538, 2013
43. Cramp F, Byron-Daniel J: Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 11:CD006145, 2012
44. Mock V, Burke MB, Sheehan P, et al: A nursing rehabilitation program for women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum 21:899-907; discussion 908, 1994
45. Mock V, Frangakis C, Davidson NE, et al: Exercise manages fatigue during breast cancer treatment: A randomized controlled trial. Psycho-oncology 14:464-477, 2005 (Pubitemid 40883418)
46. Hoffman AJ, Brintnall RA, Brown JK, et al: Too sick not to exercise: Using a 6-week, home-based exercise intervention for cancer-related fatigue self-management for postsurgical non-small cell lung cancer patients. Cancer Nurs 36:175-188, 2013
47. Dimeo F, Schwartz S, Wesel N, et al: Effects of an endurance and resistance exercise program on persistent cancer-related fatigue after treatment. Ann Oncol 19:1495-1499, 2008
48. Segal RJ, Reid RD, Courneya KS, et al: Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 27:344-351, 2009
49. Andersen C, Rørth M, Ejlertsen B, et al: The effects of a six-week supervised multimodal exercise intervention during chemotherapy on cancer-related fatigue. Eur J Oncol Nurs 17:331-339, 2013
50. Cheville AL, Kollasch J, Vandenberg J, et al: A home-based exercise program to improve function, fatigue, and sleep quality in patients with stage IV lung and colorectal cancer: A randomized controlled trial. J Pain Symptom Manage 45:811-821, 2013
51. Yeo TP, Burrell SA, Sauter PK, et al: A progressive postresection walking program significantly improves fatigue and health-related quality of life in pancreas and periampullary cancer patients. J Am Coll Surg 214:463-475; discussion 475-7, 2012
52. Mustian KM, Sprod LK, Janelsins M, et al: Exercise recommendations for cancer-related fatigue, cognitive impairment, sleep problems, depression, pain, anxiety, and physical dysfunction: A review. Oncol Hematol Rev 8:81-88, 2012
53. Sadja J, Mills PJ: Effects of yoga interventions on fatigue in cancer patients and survivors: A systematic review of randomized controlled trials. Explore 9:232-243, 2013
54. Goedendorp MM, Gielissen MF, Verhagen CA, et al: Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev 1:CD006953, 2009
55. Kwekkeboom KL, Abbott-Anderson K, Cherwin C, et al: Pilot randomized controlled trial of a patient-controlled cognitive-behavioral intervention for the pain, fatigue, and sleep disturbance symptom cluster in cancer. J Pain Symptom Manage 44:810-822, 2012
56. Montgomery GH, David D, Kangas M, et al: Randomized controlled trial of a cognitive-behavioral therapy plus hypnosis intervention to control fatigue in patients undergoing radiotherapy for breast cancer. J Clin Oncol 32:557-563, 2014
57. van Weert E, May AM, Korstjens I, et al: Cancer-related fatigue and rehabilitation: A randomized controlled multicenter trial comparing physical training combined with cognitive-behavioral therapy with physical training only and with no intervention. Phys Ther 90:1413-1425, 2010